Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajin Liu

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
BMC Cancer|August 16, 2022
Multiparameter diagnostic model based on <sup>18</sup>F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomasGuanyun Wang, Lei Du, Xia Lu, et al.
Quantitative Imaging in Medicine and Surgery|July 29, 2025
The diagnostic value of the multiparameter combination diagnostic model based on 2-[<sup>18</sup>F]FDG PET/CT metabolic parameters and clinical variables in distinguishing non-metastatic cholangiocarcinoma from cholangitisJingfeng Zhang, Jianbo Cui, Yun Han, et al.
Journal of the American Chemical Society|July 7, 2026
Enhanced Hydrogen Evolution over Single-Atom Catalysts via Electrostatic Polarization in Contact-electro-catalysisXueyan Yang, Ziming Wang, Zeyang Yu, et al.
Journal of the American Chemical Society|July 11, 2025
Unveiling Janus Chemical Processes in Contact-Electro-Chemistry through Oxygen Reduction ReactionsTing Gan, Zhe Yang, Shaoxin Li, et al.
Alzheimer'S Research & Therapy|February 18, 2025
Investigating the Aβ and tau pathology in autosomal dominant Alzheimer's disease: insights from hybrid PET/MRI and network mappingZhi Zhou, Qigeng Wang, Linwen Liu, et al.
Frontiers in Immunology|June 7, 2023
Corrigendum: The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapyGuanyun Wang, Wenwen Zhang, Xiaohui Luan, et al.
Frontiers in Immunology|May 22, 2023
The role of <sup>18</sup>F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapyGuanyun Wang, Wenwen Zhang, Xiaohui Luan, et al.
Quantitative Imaging in Medicine and Surgery|January 15, 2024
Metabolic parameters of pretreatment 2-[<sup>18</sup>F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort studyCan Li, Yanliang Dong, Yue Pan, et al.
Asian Journal of Urology|February 24, 2025
Comparison between <sup>18</sup>F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trialShaoxi Niu, Yachao Liu, Liyan Ao, et al.
Plant Phenomics (Washington, D.C.)|May 11, 2026
MSDDG: Multi-scale dual-discriminator GAN for point cloud completion of plantQingguang Chen, Jiajin Liu, Hongwei Sun, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
BMC Cancer|August 16, 2022
Multiparameter diagnostic model based on <sup>18</sup>F-FDG PET and clinical characteristics can differentiate thymic epithelial tumors from thymic lymphomasGuanyun Wang, Lei Du, Xia Lu, et al.
Quantitative Imaging in Medicine and Surgery|July 29, 2025
The diagnostic value of the multiparameter combination diagnostic model based on 2-[<sup>18</sup>F]FDG PET/CT metabolic parameters and clinical variables in distinguishing non-metastatic cholangiocarcinoma from cholangitisJingfeng Zhang, Jianbo Cui, Yun Han, et al.
Journal of the American Chemical Society|July 7, 2026
Enhanced Hydrogen Evolution over Single-Atom Catalysts via Electrostatic Polarization in Contact-electro-catalysisXueyan Yang, Ziming Wang, Zeyang Yu, et al.
Journal of the American Chemical Society|July 11, 2025
Unveiling Janus Chemical Processes in Contact-Electro-Chemistry through Oxygen Reduction ReactionsTing Gan, Zhe Yang, Shaoxin Li, et al.
Alzheimer'S Research & Therapy|February 18, 2025
Investigating the Aβ and tau pathology in autosomal dominant Alzheimer's disease: insights from hybrid PET/MRI and network mappingZhi Zhou, Qigeng Wang, Linwen Liu, et al.
Frontiers in Immunology|June 7, 2023
Corrigendum: The role of 18F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapyGuanyun Wang, Wenwen Zhang, Xiaohui Luan, et al.
Frontiers in Immunology|May 22, 2023
The role of <sup>18</sup>F-FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapyGuanyun Wang, Wenwen Zhang, Xiaohui Luan, et al.
Quantitative Imaging in Medicine and Surgery|January 15, 2024
Metabolic parameters of pretreatment 2-[<sup>18</sup>F]fluoro-D-glucose positron emission tomography for prognosis in patients with gallbladder adenocarcinoma: a cohort studyCan Li, Yanliang Dong, Yue Pan, et al.
Asian Journal of Urology|February 24, 2025
Comparison between <sup>18</sup>F-DCFPyL PET/MRI-guided ultrasound fusion targeted biopsy and systematic biopsy for tumor detection and grading in selected patients: A prospective randomized controlled trialShaoxi Niu, Yachao Liu, Liyan Ao, et al.
Plant Phenomics (Washington, D.C.)|May 11, 2026
MSDDG: Multi-scale dual-discriminator GAN for point cloud completion of plantQingguang Chen, Jiajin Liu, Hongwei Sun, et al.
Pageof 5